Release Date: 26/10/15 08:21 Summary: iSignthis Investor Presentation - October 2015 Price Sensitive: No Download Document 613.47KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%